UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

English sponsored seminar 2. CIDP – Diagnostic and therapeutic challenges

Clinical neurophysiology, 2019-10, Vol.130 (10), p.e178-e179

Kiers, Lynette

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study

BMJ neurology open, 2022-09, Vol.4 (2), p.e000328-e000328

2022

Link zum Volltext

Verfügbarkeit prüfen

High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes

Journal of neuroimmunology, 2012-09, Vol.250 (1), p.77-82

2012

Link zum Volltext

Verfügbarkeit prüfen

Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis

Journal of neuroimmunology, 2013-01, Vol.254 (1), p.174-177

2013

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barre syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series

Medical journal of Australia, 2012-11, Vol.197 (10), p.574-578

2012

Link zum Volltext

Verfügbarkeit prüfen

Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype

Neuromuscular disorders : NMD, 2009-11, Vol.19 (11), p.763-765

2009

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

Clinical cancer research, 2005-03, Vol.11 (5), p.1890-1898

2005

Link zum Volltext

Verfügbarkeit prüfen

Nitrous oxide‐induced neurological disorders: an increasing public health concern

Internal medicine journal, 2022-05, Vol.52 (5), p.740-744

2022

Link zum Volltext

Verfügbarkeit prüfen

Guillain‐Barré Syndrome in an Australian State Using Both mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines

Annals of neurology, 2021-11, Vol.90 (5), p.856-858

2021

Link zum Volltext

Verfügbarkeit prüfen

Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma

Muscle & nerve, 2015-06, Vol.51 (6), p.928-931

2015

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barré syndrome temporally associated with COVID-19 vaccines – Progress over time

Vaccine, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Reply: Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: should it be termed paraneoplastic?

Muscle & nerve, 2016-04, Vol.53 (4), p.659-659

2016

Link zum Volltext

Verfügbarkeit prüfen

2722 Use of subcutaneous immunoglobulin in the maintenance treatment of CIDP: a single-centre experience

BMJ neurology open, 2023-08, Vol.5 (Suppl 1), p.A41-A41

2023

Link zum Volltext

Verfügbarkeit prüfen

Oromandibular parafunction in chronic graft‐versus‐host disease: novel association and treatment approach

Internal medicine journal, 2021-11, Vol.51 (11), p.1950-1953

2021

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

Vaccine, 2022-12, Vol.40 (52), p.7579-7585

2022

Link zum Volltext

Verfügbarkeit prüfen

Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma: DADS with Colorectal Adenocarcinoma

Muscle & nerve, 2015-06, Vol.51 (6), p.928-931

2015

Link zum Volltext

Verfügbarkeit prüfen

Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity

Nature biotechnology, 2016-03, Vol.34 (3), p.320-327

2016

Link zum Volltext

Verfügbarkeit prüfen

4. Post-marketing safety study to evaluate the occurrence of aseptic meningitis syndrome (AMS) in an adult population (⩾18 years) treated with doses of ⩾1 g/kg INTRAGAM10

Clinical neurophysiology, 2020-03, Vol.131 (3), p.e2-e2

2020

Link zum Volltext

Verfügbarkeit prüfen

2822 From hospital to home: supporting chronic inflammatory demyelinating polyneuropathy patients on subcutaneous immunoglobulin therapy

BMJ neurology open, 2023-08, Vol.5 (Suppl 1), p.A58-A59

2023

Link zum Volltext

Verfügbarkeit prüfen

Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS

Journal of the peripheral nervous system, 2022-09, Vol.27 (3), p.197-205

2022

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy

Urology (Ridgewood, N.J.), 2016-01, Vol.87, p.133-139

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy

Annals of clinical and translational neurology, 2017-05, Vol.4 (5), p.318-325

2017

Link zum Volltext

Verfügbarkeit prüfen

Multifocal Motor Neuropathy Presenting as Pseudodystonia

Movement disorders clinical practice (Hoboken, N.J.), 2017-01, Vol.4 (1), p.100-104

2017

Link zum Volltext

Verfügbarkeit prüfen

Guillain‐Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self‐controlled case series

Medical journal of Australia, 2014-04, Vol.200 (6), p.321-321

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy

Brain and behavior, 2016-10, Vol.6 (10), p.e00516-n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(37)
Berichte
(3)

Sprache

Englisch
(40)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

English sponsored seminar 2. CIDP – Diagnostic and therapeutic challenges

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study

High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes

Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis

Guillain-Barre syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series

Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype

A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

Nitrous oxide‐induced neurological disorders: an increasing public health concern

Guillain‐Barré Syndrome in an Australian State Using Both mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines

Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma

Guillain-Barré syndrome temporally associated with COVID-19 vaccines – Progress over time

Reply: Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: should it be termed paraneoplastic?

2722 Use of subcutaneous immunoglobulin in the maintenance treatment of CIDP: a single-centre experience

Oromandibular parafunction in chronic graft‐versus‐host disease: novel association and treatment approach

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma: DADS with Colorectal Adenocarcinoma

Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity

4. Post-marketing safety study to evaluate the occurrence of aseptic meningitis syndrome (AMS) in an adult population (⩾18 years) treated with doses of ⩾1 g/kg INTRAGAM10

2822 From hospital to home: supporting chronic inflammatory demyelinating polyneuropathy patients on subcutaneous immunoglobulin therapy

Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS

Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy

Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy

Multifocal Motor Neuropathy Presenting as Pseudodystonia

Guillain‐Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self‐controlled case series

Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy

Suchergebnisse filtern